PLSE Q4 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

-$9,000-101.1% YoY

Gross Profit

-$1M14444.4% margin

Operating Income

-$9M97166.7% margin

Net Income

-$9M102188.9% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-Infinity%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$748,000

Balance Sheet

Total Assets

$78M

Total Liabilities

$80M

Stockholders' Equity

-$2M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$9,000	$844,000	-101.1%
Gross Profit	-$1M	-$397,000	-227.5%
Operating Income	-$9M	-$15M	+43.3%
Net Income	-$9M	-$15M	+40.3%